(Q41208689)

28 September 2017

1 reference

title

Antiandrogen therapy in dermatology (English)

1 reference

28 September 2017

Shaw JC

1

1 reference

28 September 2017

publication date

1 November 1996

1 reference

International Journal of Dermatology

28 September 2017

published in

1 reference

28 September 2017

volume

35

1 reference

28 September 2017

issue

11

1 reference

28 September 2017

page(s)

770-778

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

28 September 2017

1 reference

Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Letter: Breast cancer associated with administration of spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Fulminant hepatitis due to cyproterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Flutamide in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Ketoconazole Blocks Testosterone Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Ketoconazole Blocks Adrenal Steroid Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Mortality in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

Ketoconazole for hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1996.TB02970.X

10.1111/J.1365-4362.1996.TB02970.X

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference